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The Year Book series makes available in
detailed abstract form some papers considered
to be of importance published during 1975
and 1976. The Year Book of Cancer has a
large editorial board (160 members) and a
very large number of articles are considered
for inclusion. Many of the best papers have
been included and some of the not so good,
and an attempt has been made to review
these critically. An extremely wide range of
topics is covered. Cancers by site, chemo-
therapy, immunotherapy and terminal care
are dealt with. There is also some attempt to
review relevant progress in the basic sciences.
Unfortunately, the reviews are inevitably out
of date by the time of publication and this
makes them of less value. It is a fairly pain-
less way of bringing the oncologist up to date
in areas in which he has not a main interest
and, for this reason, the book has a place in a
library, butI doubt whether many individuals
will be prepared to pay the price of a review
now about two years out of date.
D. CROWTHER
Mechanisms of Tumour Promotion and
Co-carcinogenesis. (Vol. 2 of a series
on Carcinogenesis-A comprehensive
survey). Eds T. J. SLAGA, A. SWAK &
R. K. BOUTWELL. (1978) New York:
Raven Press. 588 pp. £26.00 net.
The editors have divided the book into 6
sections followed by a w-ell-presented sum-
mary. In reviewing the subject they rightly
assign the opening chapter on historical
perspectives to Berenblum who discovered
the co-carcinogenic action of croton oil.
Having made the distinction between co-
carcinogens, covering a wide range of modi-
fying influences, and tumour promoters he
reminds us of some ofthe pertinent questions
to be considered. A great deal of valuable
information on the structure-activity rela-
tionships of the diterpene esters is contained
in the chapter by Hecker, which identifies the
most active promoting agents and discusses
their metabolism and mode ofaction. A mucb
shorter contribution on the biochemical
mechanism oftumour promotion by Boutwell
emphasises the work ofhis ownn laboratory, in
which the induction of ornithine-de-
carboxylase activity in mouse epidermis by
phorbol esters is correlated with their activity
as tumour promoters. The chapter on tumour
promotion and co-carcinogenesis in relation
to our ow,n environment is more speculative,
but considers evidence for factors which en-
hance cancer of the lung, breast, colon and
upper alimentary tract in man. The final
chapter by Mueller on the possible targets of
co-carcinogenesis considers the mechanisms
of DNA and chromatin replication, and
presents a hypothesis based on observations
ofthe action ofphorbol esters onlymphocytes.
Effects of tumour promoters on mouse skin
are considered in the next section, andinclude
studies of the kinetics of skin papillomas, the
role of cyclic nucleotides, the relation of
specific proteins in the epidermis and the
information obtained from studies of the
inhibition of tumour promotion by steroids.
Certain of the biochemical evidence would
support the view that tumour promotion may
induce a dedifferentiation by modifying gene
expression. The fact that the phorbol esters
act at concentrations of the order to 10-9M
suggests that they may act via specific
receptors on the cell membrane, but their
mode of action has yet to be established.
In the section on in vitro studies, a useful
comparison is made ofthe responses of mouse
skin keratinocytes, fibroblasts and carcinoma
cells by Fusenig & Samsel. They find the
greatest effect on the epidermal target cells,
but point out that these are derived from
newborn mouse epidermis, which is not
stimulated in vivo by local applications of
TPA. The conditions for the induction of
ornithine and S-adenosylmethionine de-
carboxylases in mouse epidermal cell cultures
by tumour promoters are examined, and the
effect of polyamine biosynthesis on cellular
control is suggested as an important aspect of
the effect of tumour promoters. One point to
emerge is that an anti-inflammatory steroid